Sr One Capital Management, LP Arcellx, Inc. Transaction History
Sr One Capital Management, LP
- $295 Million
- Q3 2024
A detailed history of Sr One Capital Management, LP transactions in Arcellx, Inc. stock. As of the latest transaction made, Sr One Capital Management, LP holds 2,346,630 shares of ACLX stock, worth $186 Million. This represents 66.33% of its overall portfolio holdings.
Number of Shares
2,346,630
Previous 2,346,630
-0.0%
Holding current value
$186 Million
Previous $130 Million
51.31%
% of portfolio
66.33%
Previous 56.87%
Shares
4 transactions
Others Institutions Holding ACLX
# of Institutions
204Shares Held
44.2MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$316 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$308 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$296 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$278 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$195 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.47B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...